France vs Netherlands: Share of E. coli infections resistant to cephalosporins
France
9.1%
in 2022
Netherlands
7.6%
in 2022
France rank
41st
Netherlands rank
43rd
Share of E. coli infections resistant to cephalosporins over time
- France
- Netherlands
How they compare
France currently reports 9.1% against 7.6% in Netherlands, a difference of 1.5%.
That makes France's figure about 1.2 times Netherlands's.
Across all 6 years both countries report, France has been ahead every year.
France ranks 41st and Netherlands ranks 43rd of 46 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9.6% | 6.9% | 2.7% | France |
| 2020s | 9.5% | 7.0% | 2.5% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, France or Netherlands?
- France, at 9.1% against 7.6% in Netherlands as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between France and Netherlands?
- 1.5%, with France ahead.
- How many years of comparable data are there for France and Netherlands?
- 6 years are reported by both, from 2017 to 2022.
- How do France and Netherlands rank globally for share of e. coli infections resistant to cephalosporins?
- France ranks 41st and Netherlands ranks 43rd of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).